glp-1 news september 26 2025 Who Gets the Shot? Access by State GLP-1s and AI tools: 2025's

Simultaneous injection of green tea extract and glutathione decreased significantly the activity level of ALT, AST and ALP enzymes compared with thioacetamide group

And so, GLP-1 therapies improve weight, blood sugar and lipid profiles, and some have demonstrated cardiovascular event reduction in high-risk populations, which makes them particularly relevant for patients with RA who also have diabetes or obesity-related cardiovascular risk

But universally, women need more antioxidant support, specific B vitamins, and many of my patients require digestive and detoxification support prior to pregnancy

Weight maintenance In SURMOUNT-4, continued use held and extended weight loss versus placebo